Life science companies team up to boost sales
SOUTH EASTON, Mass. Two Massachusetts life sciences tool manufacturers recently announced a co-marketing/selling and research and development agreement to co-market and sell their respective product lines. Pressure BioSciences, Inc., in South Easton, and Digilab, Inc., of Holliston, said in a statement that their products will be sold worldwide, including in industry publications, at scientific meetings, on each companys website, through common collaborator studies, at key industry trade shows, and in visits to customer sites.
PBI and Digilab also intend to explore ways to co-develop new instrumentation, accessories/modules for existing instrumentation, and consumables that combine the robotics and high throughput capabilities of Digilab products with the extraction, protein digestion, and other advantages of PBIs Pressure Cycling Technology (PCT) Platform.
One of the most significant problems in protein studies today is the proper preparation of a sample prior to its analysis, the companies said in a statement. Poor sample preparation can lead to inaccurate results. Digilab and PBI believe that a combination of their respective proprietary technology platforms will provide scientists with an improved, more reproducible, integrated workflow to better address important sample preparation issues that are routinely encountered by scientists.
We believe that Digilabs suite of sample preparation, liquid handling, and identification products, coupled with PBIs unique pressure-based technology platform and PCT products, will offer the research scientist greatly enhanced sample preparation tools with a higher degree of reproducibility, versatility, throughput, and overall quality than currently available. We believe this will result in increased sales and visibility for both Digilab and PBI, said Sidney Braginsky, chairman and CEO of Digilab.
The companies said they believe the alliance will facilitate the introduction of respective sample preparation product lines to research laboratories worldwide without the need to increase sales staff, marketing budgets, and time at scientific meetings.
We believe this is a very cost-effective way to significantly increase market penetration and increase sales for both companies, said Richard T. Schumacher, president and CEO of Pressure BioSciences. We expect to begin to see these increased sales results during the first half of 2012.
Tags: Industry Publications